HEALTHCARE software provider Emis Group has bought a company which protects diabetes sufferers’ eyesight.
Emis Group has bought Medical Imaging (UK) and MIDRSS, which provides diabetic eye screening and ophthalmology imaging to the NHS in England. Medical Imaging also has a growing presence in Ireland’s national health service, the HSE.
In a statement, Leeds-based Emis said the acquisition is in line with the group’s strategy of providing “cross-organisational” healthcare systems.
Emis said: “The acquisition provides the group with an opportunity to further support the NHS and patients, through the delivery of services in an area closely aligned to its existing software systems.”
Medical Imaging, which is based in Worcester, reported profit before tax of approximately £1.3m on revenue of £6.3m for the year ended April 30 2014.
Chris Spencer, the chief executive of Emis Group, said: “I am delighted to welcome Medical Imaging to Emis Group. It enhances our already strong position in diabetic eye screening, achieved through the 2013 acquisition of Digital Healthcare.
“This is a growing niche market. We expect the acquisition to be not only earnings enhancing in 2015 but also to help prevent blindness in the increasing number of people suffering from diabetes.”
Martin Sweeney and Steven Millward from law firm Schofield Sweeney’s corporate team advised the EMIS Group.